AU2124592A - Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes - Google Patents

Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes

Info

Publication number
AU2124592A
AU2124592A AU21245/92A AU2124592A AU2124592A AU 2124592 A AU2124592 A AU 2124592A AU 21245/92 A AU21245/92 A AU 21245/92A AU 2124592 A AU2124592 A AU 2124592A AU 2124592 A AU2124592 A AU 2124592A
Authority
AU
Australia
Prior art keywords
nose
eyes
pharmaceutical compositions
compositions containing
local use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21245/92A
Inventor
Norbert Giessler
Heinz-Rudiger Seidel
Klaus Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU2124592A publication Critical patent/AU2124592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU21245/92A 1991-08-22 1992-08-21 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes Abandoned AU2124592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4127738 1991-08-22
DE4127738 1991-08-22

Publications (1)

Publication Number Publication Date
AU2124592A true AU2124592A (en) 1993-02-25

Family

ID=6438805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21245/92A Abandoned AU2124592A (en) 1991-08-22 1992-08-21 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes

Country Status (10)

Country Link
EP (1) EP0529499A1 (en)
JP (1) JPH05221873A (en)
KR (1) KR930003925A (en)
AU (1) AU2124592A (en)
CA (1) CA2076558A1 (en)
CZ (1) CZ256592A3 (en)
HU (1) HUT63060A (en)
IL (1) IL102885A0 (en)
NO (1) NO923293L (en)
ZA (1) ZA926313B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU696429B2 (en) * 1994-03-09 1998-09-10 Cortech, Inc. Bradykinin antagonist peptides incorporating n-substituted glycines
CN104043101A (en) * 2014-05-23 2014-09-17 杭州诺泰制药技术有限公司 Icatibant composition for injection and preparation method and preparation thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585355A (en) * 1994-04-22 1996-12-17 Alkermes, Inc. Method for increasing blood-ocular barrier permeability with permeabilizer peptides
US6531480B1 (en) 1998-04-03 2003-03-11 Alcon Manufacturing, Ltd. Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders
US6500831B1 (en) 1998-04-03 2002-12-31 Alcon Manufacturing, Ltd. Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma
DE20009841U1 (en) * 2000-05-31 2001-10-25 Phyt Immun Gmbh Vaseline-based nasal ointment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
EP0334244A3 (en) * 1988-03-25 1991-05-29 The Procter & Gamble Company Bradykinin antagonist peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (en) * 1990-08-24 1992-04-01 Syntex Inc BRADIQUININE ANTAGONISTS

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU696429B2 (en) * 1994-03-09 1998-09-10 Cortech, Inc. Bradykinin antagonist peptides incorporating n-substituted glycines
CN104043101A (en) * 2014-05-23 2014-09-17 杭州诺泰制药技术有限公司 Icatibant composition for injection and preparation method and preparation thereof
CN104043101B (en) * 2014-05-23 2016-04-20 杭州阿德莱诺泰制药技术有限公司 A kind of icatibant composition for injection and preparation method thereof and preparation

Also Published As

Publication number Publication date
ZA926313B (en) 1993-04-28
CA2076558A1 (en) 1993-02-23
JPH05221873A (en) 1993-08-31
KR930003925A (en) 1993-03-22
CZ256592A3 (en) 1993-03-17
NO923293L (en) 1993-02-23
IL102885A0 (en) 1993-01-31
EP0529499A1 (en) 1993-03-03
NO923293D0 (en) 1992-08-21
HUT63060A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
IL106927A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL105806A0 (en) Aminoquinoline derivatives and pharmaceutical compositions containing the same
AU656157B2 (en) Pharmaceutical agents
AU2087992A (en) Pharmaceutical combination formulation
IL99902A0 (en) Indane and quinoline derivatives and pharmaceutical compositions containing the same
AU638346B2 (en) Carbostyril derivatives and pharmaceutical composition containing the same
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IL111517A0 (en) Ophthalmic formulation
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
AU3152993A (en) Improvements in the administration of aerosol compounds
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
IL104623A0 (en) Biphenyl-substituted quinoline derivatives and pharmaceutical compositions containing the same
AU1227292A (en) Pharmaceutical antitussive compositions
AU2124592A (en) Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes
GB9216061D0 (en) Pharmaceutical combination formulation
AU6361494A (en) Anhydroretinol and derivatives thereof as antagonists
ZA944187B (en) Ipsapirone medicament formulation
IL97708A0 (en) Pharmaceutical compositions containing piperidinyl-benzocycloheptathiophenone derivatives and methods for the use thereof
IL107368A0 (en) Inositol derivatives and their pharmaceutical use
HU9803012D0 (en) N-cycloalkyl-amine-derivatives and pharmaceutical compositions containing the same
IL103091A0 (en) Taste-making pharmaceutical compositions and methods for making the same
GB9322907D0 (en) Pharmaceutical formulation
GB9312705D0 (en) Pharmaceutical formulation
GB9305439D0 (en) Pharmaceutical formulation